Optimizing oxygen delivery improves stem cell treatment of peripheral artery disease
A Painful Narrowing of Options
One in three people over the age of 70 suffers from peripheral artery disease (PAD), a narrowing of arteries that occurs most often in the legs. Plaque, a substance composed of cholesterol, calcium and fibrous tissue, builds up in the arteries and hardens over time, reducing blood flow. Symptoms range from pain to difficulty fighting infection and in severe cases, tissue death. Treatment with adipose-derived stem cells offers great promise for restoring blood flow, but the inherently oxygen-deprived environment causes the majority of stem cells to die before they can be of regenerative benefit.
Oxygen Delivery – On Demand
A collaboration between two labs at the University of Texas at Austin is working on a controlled oxygen delivery system to improve the survival of stem cells during treatment and thereby promote growth of new blood vessels. The teams are planning to add oxygen-saturated perfluorocarbon (PFC) nanodroplets to the hydrogel stem cell carrier destined for implantation at the treatment site. Oxygen would then be released from the nanodroplets into the surrounding tissue through passive diffusion at a rate that depends on the composition of the nanodroplet shell and the implantation environment.
Additionally, a more dramatic oxygen release can be accomplished via laser “activation” of the nanodroplets. Irradiation at specific wavelengths, dependent upon absorbers encapsulated within the PFC nanodroplets, causes a rapid phase-change into a microbubble, faciliating oxygen release. This allows the location and timing of oxygen delivery to the treatment area to be controlled and tunable on a per patient basis.
Success with an Optical Oxygen Sensor
As a first step, the researchers looked at oxygen release in solution. Galvanic oxygen probes proved unsuitable, being too bulky and prone to interference from the bubbles that occurred during activation, resulting in inaccurate measurements. Instead the team chose our NeoFox optical oxygen sensor based on phase fluorimetry. It is immune to most environmental effects and can be configured with a probe that is <1 mm in diameter for use in small samples.
In testing, a marked increase in oxygen levels was seen for the nanodroplet-containing solutions as compared with the control, scaling with concentration. Use of higher activating laser intensity also increased oxygen release. Most importantly, the oxygen release achieved appears to be sufficient to boost oxygenation to levels that will increase implanted stem cell survival and lead to improved therapeutic outcomes for PAD patients.
Continuing Medical Progress
The next steps for the group at UT Austin will be to repeat these experiments in a hydrogel format, followed by in situ tissue studies. The small size of the NeoFox oxygen probe and its ability to work in different media will allow the team to use a single system for the full scope of research, and speed their progress in improving the effectiveness of a promising treatment for peripheral artery disease. To keep current on the UT team’s progress, visit the websites for the Suggs Lab and the Ultrasound Imaging and Therapeutics Research Laboratory.
Optical System – Oxygen Sensing
- NeoFox-GT phase fluorimeter system
- FOSPOR-PI600 polyimide-coated oxygen probe with FOSPOR high sensitivity coating
- BIFBORO-600-2 bifurcated optical fiber and 21-02 SMA splice bushing
- FOSPOR-CAL calibration service for oxygen probe (custom oxygen and temperature range)
- NEOFOX-TP thermistor for temperature compensation